>爱游戏首页 >爱游戏新闻 >集团新闻 > 爱游戏-嘉宾阵容公布!Global XDC 2024大咖云集,精彩一触即发

爱游戏-嘉宾阵容公布!Global XDC 2024大咖云集,精彩一触即发

发布时间:2024-11-30  |  作者:爱游戏

佳宾声势发布!Global XDC 2024年夜咖云集,出色剑拔弩张

由药明合联WuXi XDC和佰傲谷BioValley配合主办的第三届生物偶联药全球立异峰会(Global XDC 2024),将在9月10-12日在无锡重磅回归。

作者: 生物前哨 来历: 生物前哨 2024-08-20 15:48:19

2024第三届生物偶联药全球立异峰会9月无锡召开!近百位国际生命科学年夜咖齐聚无锡,摸索偶联药的无穷可能!

图片1.png

由药明合联WuXi XDC和佰傲谷BioValley配合主办的2024第三届生物偶联药全球立异峰会(Global XDC 2024),将在9月10-12日在无锡重磅回归。年夜会涵盖2个主论坛+4个分论坛,估计参会企业300+家,参会专家100+位,参会不雅众1000+人。年夜会以“摸索偶联药的无穷可能”为主题,将聚焦在新靶点发现与验证、ADC和新型偶联药物立异手艺、载荷-毗连子新手艺,和CMC挑战和贸易化策略等内容,摸索前沿手艺前进、分享国际优异生物科技公司的立异经验、引领ADC和XDC的新将来!

本届峰会约请了浩繁生物偶联药范畴的国际专家预会,配合切磋立异合作,碰撞思惟,助力生物偶联药行业蓬勃成长。

1.国际佳宾声势来袭,凝听偶联药的世界声音

图片2.png

2.精选热点议题一览,摸索偶联药的无穷可能

图片3.png

Keynote Speech

lRina-S-the missing link(er)

lProtein homeostasis by dual-precision targeted protein degradation and stabilization

lA novel dual-payload ADC platform to overcome payload resistance and maximize therapeutic promise of ADCs

lMYTX-011: a cMET-targeting ADC engineered for anti-tumor activity against a broader spectrum of cMET expression

lNTX1105: development of a best-in-class ADC targeting Nectin-4

lCollaborating within the global life science ecosystem to advance breakthrough science

论坛一:Next generation ADCs: Novel targets, payloads, payload-linkers, and conjugation technologies

lNext generation ADCs: novel targets, payloads, linkers and conjugation technologies

lNexatecan™: OHPAS-able Topo1 inhibitor for ADC

lIntroduction to PINOT-ADC platform: novel Top1 inhibitor payload, tandem cleavable and super-hydrophilic linker, and dual payload system

lVersatile drug bundle-based ADC platform: achieving site-specific conjugation, DAR of 8 or 12, and dual payloads

lCS5001, a potential best-in-class ROR1 ADC

lDiscovery of AT65474, a highly selective anti-CLDN6 ADC with a proprietary payload

lPolysorbates in biopharmaceuticals-approaches to mitigate risk

论坛二:Bioconjugates development beyond ADCs

lRDC-the exploration of new drug modality in unmet clinical need

lIntra-cellular mutant epitopes-novel targets for ADC and bispecific antibodies?

lGBB’s AI-enabled ecosystem elevating biological drug development

lDeveloping radiopharmaceuticals targeting CLDN 18.2 with nanobodies

lFully human common light chain technology for novel ADCs

论坛三:Innovative bioconjugate discovery: from target selection to PreClinical Candidate (PCC)

lHarnessing AbClick Pro®for AT-211: leading CLDN 18.2 ADCs with superior therapeutic index

lAn overview on the new topoisomerases inhibitors technologies

lNext generation ADCs:novel targets, payloads, linkers and conjugation technologies

lChallenges and solutions for clinical PK bioanalysis of antibody drug conjugates (ADCs)

论坛四:CMC challenges and commercialization strategies

lCMC scale-up challenges and COGs for site specific ADCs

lInnovative bioassays: translate clinical effects into a rigorous system of XDC product assessment

lThe integrated analytical platform enables accelerated CMC development of XDCs

lQbD considerations for ADC process

lHow WuXiBio’s Microbial Platform facilitates rapid and cost-effective ADC development and manufacturing

lNon-clinical strategies for ADC drugs

3.接待更多XDC研发企业插手我们

主办单元:药明合联WuXi XDC、佰傲谷BioValley

年夜会时候:2024年9月10-12日(周二/周三/周四)

年夜会地址:中国·无锡君来洲际酒店

参会报名:扫码下方二维码报名

图片4.png

【尺度通票:200元/人】

联系我们:定制参展/商务合作请联系:Stephen Sun15966587556(微信同号)

参会报名/媒体合作请联系:Abby Jiang18217659261(微信同号)

图片5.png

4.特殊感激以下单元的撑持

图片6.png

图片7.png

第三届生物偶联药全球立异峰会 生物科技

存眷年夜健康Pai 官方微信:djkpai我们将按期推送医健科技财产最新资讯

最新快讯 医健资讯| 必看!BioONE2024生物工艺年会参...

2024-11-08

上一篇:爱游戏-新进展!这几个省级区域医疗中心项目有序推进中~ 下一篇:爱游戏-官宣
电话: (86)0531-86997280
版权所有: 爱游戏 All Rights Reserved 鲁ICP备12019481号-1 互联网药品信息服务资格证书编号: (鲁)-非经营性-2015-0114